Sesquiterpene lactone compounds, preparation method thereof and application to preparation of NPC (nasopharyngeal carcinoma) preventing and treating drugs
A technology of ester compounds and sesquiterpenes, applied in the field of compounds and medicines, can solve the problems of easy metastasis and recurrence, no specific anti-nasopharyngeal carcinoma, poor patient compliance with treatment, etc., so as to inhibit the proliferation of nasopharyngeal carcinoma cells and promote the The effect of cancer cell apoptosis and high anti-nasopharyngeal carcinoma activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0050] Compounds XF-1 to XF-18 were prepared from Inula flower (Euphorbia antiquorum L.).
[0051] The dried inflorescences of Inula inula were extracted three times with 95% ethanol water at room temperature, each time for 72 hours, and the extract was concentrated under reduced pressure to obtain a crude extract. The crude extract was suspended in water, extracted with ethyl acetate, and concentrated under reduced pressure to obtain the ethyl acetate fraction, which was chromatographed on a silica gel column (100-200 mesh) and eluted with petroleum ether / ethyl acetate gradient (9:1, 8:2,2:1,1:2,0:1), after TLC detection, it was divided into 3 components (A-C). Part B (54 g) was subjected to reverse phase column chromatography, eluting with methanol / water (50%-100%) to obtain seven fractions Fr.B1-7. Fr.B2 was eluted with Sephadex LH-20 with dichloromethane / methanol (1:1) to obtain compounds XF-1 (120mg), XF-2 (2.3g), XF-3 (50mg), XF-4 (20mg). Fr.B3 was separated by HPLC t...
Embodiment 2
[0053] Preparation of Ergolide Derivatives XF2-1~XF2-30
[0054] Synthetic route a: at room temperature, the compound Ergolide (XF2, 10mg, 0.03mmol) and the catalytic equivalent of 10% Pd / C were dissolved in 2mL of methanol, in H 2 Under conditions, stir for 1h. The completion of the reaction was monitored by low-resolution mass spectrometry, the device was removed, Pd / C was removed by filtration with a microporous membrane, and concentrated under reduced pressure to obtain white solid XF2-1 (10 mg, 100%).
[0055] b: Dissolve the compound Ergolide (50mg, 0.17mmol) in tetrahydrofuran (2mL), stir in an ice bath, add 5e.q lithium hydroxide (20mg, 0.85mmol) dissolved in 1mL ethanol / water (1 / 1), TLC Monitor the reaction. After the reaction is complete, spin dry and add an appropriate amount of saturated saline, add concentrated hydrochloric acid dropwise in an ice bath, and precipitate a white solid Carpesiolin (XF-1, 37mg, 85%)
[0056] c: Put the compound Ergolide (20mg, 0.08m...
Embodiment 3
[0064] Prepare formula (I) earlier by the method of embodiment 1 and 2, add water for injection according to routine, fine filter, potting sterilization makes injection solution.
PUM
Property | Measurement | Unit |
---|---|---|
pore size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com